Download A4Medicine Mobile App

Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀

A4Medicine

Risk assessment and prescribing of adrenaline devices -Adrenaline Auto-Injectors (AAIs)

Anaphylaxis is a potentially life-threatening allergic reaction that can present in primary care. General practitioners play a critical role in identifying patients at risk, managing emergencies, and prescribing adrenaline auto-injectors to mitigate future risks. This guide provides a structured approach to risk assessment, prescribing, and patient education, ensuring safe and effective management in line with RCGP curriculum competencies.


Key Points for GPs: Adrenaline Auto-Injectors (AAIs)

  • AAIs are the first-line emergency treatment for anaphylaxis.

  • Risk assessment is guided by clinical history, not solely allergy testing.

  • Prescribe two devices for patients at significant risk and refer to an allergy specialist for further evaluation.

  • Ensure patients and carers receive training on AAI administration and have a written anaphylaxis action plan.


STEP 1- when to consider


Indication Examples / Notes
Previous anaphylaxis of unknown cause Idiopathic anaphylaxis
Anaphylaxis with unavoidable trigger Bee/wasp stings, common food allergens (e.g., nuts, shellfish)
Allergy to high-risk allergens + additional risk factors Peanuts, tree nuts + asthma, poorly controlled asthma, adolescence (higher risk group)
Reaction to trace amounts of allergen Highly sensitive individuals
Co-morbidities increasing risk Asthma, mastocytosis, ↑ baseline tryptase
Post-emergency treatment for anaphylaxis After hospital/ED discharge for anaphylaxis
High risk of exposure to known allergens...

Try our Free Plan to get the full article.